140
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Synthesis, X-ray crystal structure, Hirshfeld surface analysis and computational investigation into the potential inhibitory action of novel 6-(p-tolyl)-2-((p-tolyl)thio)methyl-7H-[1.2.4]triazolo[5,1-b][1,3,4]thiadiazine inhibits the main protease of COVID-19

, ORCID Icon, , , , , & ORCID Icon show all
Pages 14275-14284 | Received 16 Aug 2022, Accepted 08 Feb 2023, Published online: 16 Feb 2023

References

  • Abro, A., & Azam, S. S. (2016). Binding free energy based analysis of arsenic (+ 3 oxidation state) methyltransferase with S-adenosylmethionine. Journal of Molecular Liquids, 220, 375–382. https://doi.org/10.1016/j.molliq.2016.04.109
  • Aytaç, P. S., Durmaz, I., Houston, D. R., Çetin-Atalay, R., & Tozkoparan, B. (2016). Novel triazolothiadiazines act as potent anticancer agents in liver cancer cells through Akt and ASK-1 proteins. Bioorganic & Medicinal Chemistry, 24(4), 858–872. https://doi.org/10.1016/j.bmc.2016.01.013
  • Bhat, E. A., Khan, J., Sajjad, N., Ali, A., Aldakeel, F. M., Mateen, A., Alqahtani, M. S., & Syed, R. (2021). SARS-CoV-2: insight in genome structure, pathogenesis and viral receptor binding analysis–an updated review. International Immunopharmacology, 95, 107493. https://doi.org/10.1016/j.intimp.2021.107493
  • Case, D. A., Aktulga, H. M., Belfon, K., Ben-Shalom, I. Y., Brozell, S. R., Cerutti, D. S., Cheatham, T. E., III, Cisneros, G. A., Cruzeiro, V. W. D., & Darden, T. A. (2021). Amber 2021. University of California Press.
  • Casewit, C. J., Colwell, K. S., & Rappe, A. K. (1992). Application of a universal force field to organic molecules. Journal of the American Chemical Society, 114(25), 10035–10046. https://doi.org/10.1021/ja00051a041
  • Cousins, K. R. (2011). Computer review of ChemDraw ultra 12.0. ACS Publications.
  • Dong, E., Du, H., & Gardner, L. (2020). An interactive web-based dashboard to track COVID-19 in real time. The Lancet Infectious Diseases, 20(5), 533–534. https://doi.org/10.1016/S1473-3099(20)30120-1
  • Douangamath, A., Fearon, D., Gehrtz, P., Krojer, T., Lukacik, P., Owen, C. D., Resnick, E., Strain-Damerell, C., Aimon, A., Ábrányi-Balogh, P., Brandão-Neto, J., Carbery, A., Davison, G., Dias, A., Downes, T. D., Dunnett, L., Fairhead, M., Firth, J. D., Jones, S. P., … Walsh, M. A. (2020). Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease. Nature Communications, 11(1), 1–11. https://doi.org/10.1038/s41467-020-18709-w
  • Dror, A. A., Eisenbach, N., Taiber, S., Morozov, N. G., Mizrachi, M., Zigron, A., Srouji, S., & Sela, E. (2020). Vaccine hesitancy: the next challenge in the fight against COVID-19. European Journal of Epidemiology, 35(8), 775–779. https://doi.org/10.1007/s10654-020-00671-y
  • Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., Scalmani, G., Barone, V., Petersson, G. A., & Nakatsuji, H. (2016). Gaussian 16.
  • Genheden, S., & Ryde, U. (2015). The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opinion on Drug Discovery, 10(5), 449–461. https://doi.org/10.1517/17460441.2015.1032936
  • Huey, R., Morris, G. M., & Forli, S. (2012). Using AutoDock 4 and AutoDock vina with AutoDockTools: A tutorial. The Scripps Research Institute Molecular Graphics Laboratory, 10550, 92037.
  • Jilloju, P. C., Persoons, L., Kurapati, S. K., Schols, D., De Jonghe, S., Daelemans, D., & Vedula, R. R. (2022). Discovery of (±)-3-(1 H-pyrazol-1-yl)-6, 7-dihydro-5 H-[1, 2, 4] triazolo [3, 4-b][1, 3, 4] thiadiazine derivatives with promising in vitro anticoronavirus and antitumoral activity. Molecular Diversity, 26, 1357–1371.
  • Kamel, M. M., & Abdo, N. Y. M. (2014). Synthesis of novel 1, 2, 4-triazoles, triazolothiadiazines and triazolothiadiazoles as potential anticancer agents. European Journal of Medicinal Chemistry, 86, 75–80. https://doi.org/10.1016/j.ejmech.2014.08.047
  • Kaplancıklı, Z. A., Turan-Zitouni, G., Özdemir, A., & Revial, G. (2008). New triazole and triazolothiadiazine derivatives as possible antimicrobial agents. European Journal of Medicinal Chemistry, 43(1), 155–159.
  • Khan, I., Hameed, S., Al-Masoudi, N. A., Abdul-Reda, N. A., & Simpson, J. (2015). New triazolothiadiazole and triazolothiadiazine derivatives as kinesin Eg5 and HIV inhibitors: Synthesis, QSAR and modeling studies. Zeitschrift für Naturforschung B, 70(1), 47–58. https://doi.org/10.1515/znb-2014-0162
  • Khan, I., Ibrar, A., & Abbas, N. (2013). Triazolothiadiazoles and triazolothiadiazines–biologically attractive scaffolds. European Journal of Medicinal Chemistry, 63, 854–868. https://doi.org/10.1016/j.ejmech.2013.01.060
  • Khan, J., Asoom, L. I., Al, Khan, M., Chakrabartty, I., Dandoti, S., Rudrapal, M., & Zothantluanga, J. H. (2021). Evolution of RNA viruses from SARS to SARS-CoV-2 and diagnostic techniques for COVID-19: A review. Beni-Suef University Journal of Basic and Applied Sciences, 10(1), 1–14. https://doi.org/10.1186/s43088-021-00150-7
  • Kokic, G., Hillen, H. S., Tegunov, D., Dienemann, C., Seitz, F., Schmitzova, J., Farnung, L., Siewert, A., Höbartner, C., & Cramer, P. (2021). Mechanism of SARS-CoV-2 polymerase stalling by remdesivir. Nature Communications, 12(1), 1–7. https://doi.org/10.1038/s41467-020-20542-0
  • Kumar, D., Jahan, S., Khan, A., Siddiqui, A. J., Redhu, N. S., Khan, J., Banwas, S., Alshehri, B., Alaidarous., & M., Wahajuddin. (2021). Neurological manifestation of SARS-CoV-2 induced inflammation and possible therapeutic strategies against COVID-19. Molecular Neurobiology, 58(7), 3417–3434. https://doi.org/10.1007/s12035-021-02318-9
  • Liu, Y.-C., Kuo, R.-L., & Shih, S.-R. (2020). COVID-19: The first documented coronavirus pandemic in history. Biomedical Journal, 43(4), 328–333. https://doi.org/10.1016/j.bj.2020.04.007
  • Miertuš, S., Scrocco, E., & Tomasi, J. (1981). Electrostatic interaction of a solute with a continuum. A direct utilizaion of AB initio molecular potentials for the prevision of solvent effects. Chemical Physics, 55(1), 117–129. https://doi.org/10.1016/0301-0104(81)85090-2
  • Miller III, B. R., McGee, Jr, T. D., Swails, J. M., Homeyer, N., Gohlke, H., & Roitberg, A. E. (2012). MMPBSA. py: An efficient program for end-state free energy calculations. Journal of Chemical Theory and Computation, 8(9), 3314–3321. https://doi.org/10.1021/ct300418h
  • Mohamadian, M., Chiti, H., Shoghli, A., Biglari, S., Parsamanesh, N., & Esmaeilzadeh, A. (2021). COVID‐19: Virology, biology and novel laboratory diagnosis. The Journal of Gene Medicine, 23(2), e3303. https://doi.org/10.1002/jgm.3303
  • Mohsen, U. (2012). Biological evaluation of some triazole and triazolothiadiazine derivatives. Marmara Pharmaceutical Journal, 16(3), 229–234.
  • Pandey, V. K., Tusi, Z., Tusi, S., & Joshi, M. (2012). Synthesis and biological evaluation of some novel 5-[(3-aralkyl amido/imidoalkyl) phenyl]-1, 2, 4-triazolo [3, 4-b]-1, 3, 4-thiadiazines as antiviral agents. International Scholarly Research Notices. https://doi.org/10.5402/2012/760517
  • Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera—a visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/10.1002/jcc.20084
  • Roe, D. R., & Cheatham III, T. E. (2013). PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. Journal of Chemical Theory and Computation, 9(7), 3084–3095. https://doi.org/10.1021/ct400341p
  • Rudrapal, M., Celik, I., Khan, J., Ansari, M. A., Alarousy, R. M. I. I., Yadav, R., Sharma, T., Tallei, T. E., Pasala, P. K., & Sahoo, R. K. (2022). Identification of bioactive molecules from Triphala (Ayurvedic herbal formulation) as potential inhibitors of SARS-CoV-2 main protease (Mpro) through computational investigations. Journal of King Saud University-Science, 10437–10453.
  • Rudrapal, M., Issahaku, A. R., Agoni, C., Bendale, A. R., Nagar, A., Soliman, M. E., S., & Lokwani, D. (2022). In silico screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 40(20), 10437–10453.
  • Rudrapal, M., Khairnar, S. J., Borse, L. B., & Jadhav, A. G. (2020). Coronavirus disease-2019 (COVID-19): An updated review. Drug Research, 70(09), 389–400.
  • Salem, M. E., Darweesh, A. F., & Elwahy, A. H. M. (2020). Synthesis of novel scaffolds based on thiazole or triazolothiadiazine linked to benzofuran or benzo [d] thiazole moieties as new hybrid molecules. Synthetic Communications, 50(2), 256–270. https://doi.org/10.1080/00397911.2019.1694689
  • Sever, B., Altıntop, M. D., Kuş, G., Özkurt, M., Özdemir, A., & Kaplancıklı, Z. A. (2016). Indomethacin based new triazolothiadiazine derivatives: Synthesis, evaluation of their anticancer effects on T98 human glioma cell line related to COX-2 inhibition and docking studies. European Journal of Medicinal Chemistry, 113, 179–186. https://doi.org/10.1016/j.ejmech.2016.02.036
  • Sheldrick, G. M. (2015). Crystal structure refinement with SHELXL. Acta Crystallographica Section C: Structural Chemistry, 71, 3–8. https://doi.org/10.1107/S2053229614024218
  • Spackman, P. R., Turner, M. J., McKinnon, J. J., Wolff, S. K., Grimwood, D. J., Jayatilaka, D., & Spackman, M. A. (2021). CrystalExplorer: A program for Hirshfeld surface analysis, visualization and quantitative analysis of molecular crystals. Journal of Applied Crystallography, 54(3), 1006–1011. https://doi.org/10.1107/S1600576721002910
  • Studio, D. (2008). Discovery Studio. Accelrys [2.1]
  • Turner, P. (2005). XMGRACE, Version 5.1. 19. Cent Coast Land-Margin Res Oregon Grad Inst Sci Technol Beavert.
  • Ye, Q., Lu, S., & Corbett, K. D. (2021). Structural basis for SARS-CoV-2 nucleocapsid protein recognition by single-domain antibodies. Frontiers in Immunology, 12 https://doi.org/10.3389/fimmu.2021.719037

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.